Abstract
Background
The advent of effective antiviral medications has revolutionised the management of the HIV-infected patients. Although this has helped in achieving prolonged symptom control, high numbers of these patients are left with the stigmata of complications associated with the medication. Lipodystrophy, either as lipoatrophy or lipohypertrophy, is a known complication of long-term HIV infection and aggressive antiviral therapy, leading to significant physical and psychological morbidity in these patients.
Methods
Eleven patients demonstrating HIV-related anterolateral neck lipohypertrophy were offered the option of an open cervicoplasty involving pre- and subplatysma lipectomy, platysmaplasty, liposuction, and face-lift in selected patients.
Results
The amount of adipose tissue excised from each patient was higher than that normally achieved through liposuction, with the highest total of 140 g in one patient. The degree of cervical contouring was significant, with all patients reporting profound satisfaction in terms of restoration of a cosmetically acceptable neck contour. Complications included two hematomas and one seroma. There was no incidence of infection.
Conclusion
Open anterior cervicoplasty with subplatysma contouring is a powerful tool for predictable and safe results and should be considered as one of the valuable treatment options for HIV-related anterolateral neck lipohypertrophy. Although the incidence of complications is higher than that for similar non-HIV patients, the degree of improvement it provided was perceived by patients as very rewarding.
Similar content being viewed by others
References
Miller J, Carr A, Smith D et al (2000) Lipodystrophy following antiretroviral therapy of primary HIV infection. AIDS 14:2406–2407
Gervasoni C, Ridolfo A, Triffiro G et al (1999) Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 13:456–471
Davidson S, Timpone J, Hannan C (2007) Surgical algorithm for management of HIV lipodystrophy. Plast Reconstr Surg 120:1843–1858
Miller K, Jones E, Yanovski J et al (1998) Visceral abdominal fat accumulation associated with use of indinviar. Lancet 351:870–875
Buss N, Duff F (1999) Protease inhibitors in HIV infection: lipodystrophy may be a consequence of prolonged survival. BMJ 318:122
Gold D, Annino D (2005) HIV-associated cervicodorsal lipodystrophy: etiology and management. Laryngoscope 115:791–795
Wolfort FG, Cetrulo CL, Nevarre DR (1999) Suction-assisted lipectomy for lipodystrophy syndromes attributed to HIV-protease inhibitor use. Plast Reconstr Surg 104:1814–1820
Gervasoni C, Ridolfo AL, Vaccarezza M et al (2004) Long term efficiency of the surgical treatment of buffalo hump in patients continuing antiretroviral therapy. AIDS 18:574–576
Carr A (2003) HIV lipodystrophy case definition study group. An objective case definition of lipodystrophy in HIV-infected adults: a case control study. Lancet 361:726–735
Carr A, Samaras K, Burton S et al (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia, and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51–F58
Talmor M, Hoffman L, LaTrenta GS (2002) Facial atrophy in HIV-related fat distribution syndrome: anatomic evaluation and surgical reconstruction. Ann Plast Surg 49:11–18
Carr A, Cooper DA (2000) Adverse effects of antiretroviral therapy. Lancet 356:1423–1430
Corcoran C, Grinspoon S (1999) The use of testosterone in the AIDS wasting syndrome. AIDS Clin Care 11:25–27
Rietschel P, Hadigan C, Cocoran C et al (2001) Assessment of growth hormone dynamics in human immunodeficiency virus related lipodystrophy. J Clin Endocrinol Metab 86:504–508
Torres RA, Unger KW, Cadman JA, Kassous JY (1999) Recombinant human growth hormone improves truncal adiposity and ‘buffalo humps’ in HIV-positive patients on HAART. AIDS 13:2479–2481
Hadigan C, Corcoran C, Basgoz N et al (2000) Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial. JAMA 284:472–478
Wolfort FG, Cetrulo CL, Nevarre DR (1999) Suction-assisted lipectomy for lipodystrophy syndrome attributed to HIV-protease inhibitor use. Plast Reconstr Surg 104:1814–1816
Chastain MA, Chastain JB, Colman WP (2001) HIV lipodystrophy: review of the syndrome and report of a case treated with liposuction. Dermatol Surg 27:497–500
Rohrich RJ, Kenkel JM (1999) Suction-Assisted lipectomy for lipodystrophy syndromes attributed to HIV protease inhibitor use. Plast Reconstr Surg 104:1821–1822
Hultman CS, McPhail L, Donaldson JH, Wohl DA (2007) Surgical management of HIV-associated lipodystrophy: role of ultrasonic assisted liposuction and suction-assisted lipectomy in the treatment of lipohypertrophy. Plast Reconstr Surg 58:255–263
Nelson L, Stewart KJ (2008) Plastic surgical options for HIV-associated lipodystrophy. J Plast Reconstr Aesthet Surg 61:359–365
Knize DM (1998) Limited incision submental lipectomy and platysmaplasty. Plast Reconstr Surg 101:473–481
Zins JE, Fardo D (2005) The ‘anterior only’ approach to neck rejuvenation: an alternative to face lift surgery. Plast Reconstr Surg 115:1761–1768
Bitner JB, Friedman O, Farrior RT, Cook TA (2007) Direct submentoplasty for neck rejuvenation. Arch Facial Plast Surg 9:194–200
Warren AG, Borud LJ (2008) Excisional lipectomy for HIV-associated cervicodorsal lipodystrophy. Aesthet Surg J 28:147–152
Conflicts of interest
The authors confirm that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ion, L., Raveendran, S.S. Open Neck Lipectomy for Patients with HIV-Related Cervical Lipohypertrophy. Aesth Plast Surg 35, 953–959 (2011). https://doi.org/10.1007/s00266-011-9711-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-011-9711-2